BrainZell
PrivateLast Round
Grant
Dec 1, 2025
Est. Valuation
$7.57M
Total Funding Raised
$1.65M
Company Overview
BrainZell operates in Healthcare & Life Sciences and is based in Stockholm. Its latest recorded funding round was a Grant round in December 2025.
BrainZell is a biotechnology company that develops stem cell-derived human brain organoid models for drug discovery and toxicity testing.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BrainZell Comparables
Compare BrainZell with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| a:head bio AG | 84% | |
| 28bio | 82% | |
| Herophilus | 81% |
For institutional investors. Book with your work email.
BrainZell Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 1, 2025 | ||||
| Seed | Aug 27, 2024 | ||||
| Accelerator | Jun 1, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
BrainZell Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Life Science Invest | Seed |
| Life Science Invest | Seed |
| Norrsken Accelerator | Seed, Accelerator |
| Vinnova | Grant |
| Industrifonden | Seed |
| The Creator Fund | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 27, 2024
$1.47M raised led by Industrifonden.
- Jun 1, 2024
$125K raised from Norrsken Accelerator
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- partners_withOct 26, 2026
BrainZell AB and Stardots partner through Cross-AI to explore how drug responses in patient-derived neural organoids relate to measurements in people, with bipolar disorder as the initial research direction, on Oct 26th '26.
For institutional investors. Book with your work email.
BrainZell Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about BrainZell's valuation, stock price, and market status.
Is BrainZell a public or private company?
BrainZell is a private company.
What is the current stock price of BrainZell?
BrainZell is a private company, so its shares have no public market price. Caplight tracks BrainZell's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BrainZell worth (valuation)?
BrainZell's valuation is estimated at $7.6M based on funding round data.
Can I buy BrainZell stock?
BrainZell shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BrainZell's last funding round?
BrainZell's most recent funding round was Grant on December 1, 2025.
Who are the main investors in BrainZell?
Key investors in BrainZell include Norrsken Accelerator, Industrifonden.
Will BrainZell IPO soon?
No public IPO plans have been announced for BrainZell.
How can I track BrainZell secondary market activity?
Caplight tracks bids, offers, and trades in BrainZell's shares on secondary markets.